Key information
- Atezolizumab in the treatment of metastatic triple-negative breast cancer.
Professional Details
Centro Médico Teknon
SPECIALIST PHYSICIAN MEDICAL ONCOLOGY
July 2023 -
Present
Hospital Quirónsalud Barcelona
SPECIALIST PHYSICIAN MEDICAL ONCOLOGY
October 2020 -
Present
Hospital El Pilar
SPECIALIST PHYSICIAN MEDICAL ONCOLOGY
September 2022 -
Present
Atezolizumab in the treatment of metastatic triple-negative breast cancer.
Journal Article
Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy.
Clinical Trial, Phase II, Journal Article
Pembrolizumab plus eribulin in hormone-receptor-positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase ? trial.
Journal Article
Make an appointment with this professional


































